Mark G. Edwards's most recent trade in Acelrx Pharmaceuticals Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acelrx Pharma Inc | Mark G. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharma Inc | Mark G. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 10,000 | 261,250 (0%) | 0% | 0 | Common Stock |